Home › Myasthenia Gravis › Indiana
Myasthenia Gravis clinical trials in Indiana
3 studies for Myasthenia Gravis are looking for participants at sites in Indiana.
Cities in Indiana
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
- Josephson Wallack Munshower Neurology, PC, Indianapolis
RecruitingPhase 3
Ages 18 to 74 · All sexes · Updated Sep 25, 2026 · NCT07217587KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
- Indiana University Health, Indianapolis
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Jul 29, 2026 · NCT06193889The ME&MG Digital Solution for Autonomous Assessment of Myasthenia Gravis
- Indiana University Health, Indianapolis
RecruitingHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Apr 11, 2025 · NCT05564936From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.